AREV Life Sciences Global Corp. announced non-brokered private placement of up to 25,160,000 units at a price of CAD 0.30 per unit for gross proceeds of up to CAD 7,548,000 on March 14, 2023. Each unit will consist of one common share and one common share purchase warrant, each whole warrant entitles the holder thereof to purchase one additional common share at a price of CAD 0.50 per share.

on the date that is 24 months from the date of issuance of the warrants; except that, if over a period of 10 consecutive trading days between the date that is 4 months and a day from the date of issuance of the warrants and the date that the warrants would otherwise expire. Securities issued will be subject to a four month and one day hold period in Canada commencing on the closing date. Finders' fees may be paid in cash, shares or warrants, or a combination of the forgoing, subject to the board approval and in accordance with the policies of the CSE.